iCAD, Inc. provides artificial intelligence-powered cancer detection. Its ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Cancer Detection segment solutions include advanced artificial intelligence and image analysis workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, a range of upgradeable computer-aided detection systems and workflow solutions for digital breast tomosynthesis, full-field digital mammography, magnetic resonance imaging and computed tomography. ProFound Suite offers 360-degree solutions for cancer detection, density assessment, and personalized risk evaluation, all based on a 2D or 3D mammogram’s collection of images. ProFound Density Assessment standardizes and simplifies breast density reporting, algorithmically examining a woman’s breast anatomy from the mammogram image.
종목 코드 ICAD
회사 이름ICAD Inc
상장일Dec 13, 1984
CEOMs. Dana R. Brown
직원 수66
유형Ordinary Share
회계 연도 종료Dec 13
주소98 Spit Brook Rd Ste 100
도시NASHUA
증권 거래소Euronext Paris
국가United States of America
우편 번호03062-5737
전화16038825200
웹사이트https://www.icadmed.com/
종목 코드 ICAD
상장일Dec 13, 1984
CEOMs. Dana R. Brown
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음